Dr. Neal K. Lakdawala, MD

Dr. Lakdawala practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Lakdawala's NPI, 1235101890, was assigned on February 7, 2006. Dr. Lakdawala graduated from University of Texas Medical School at San Antonio in 2001. Dr. Lakdawala holds Massachusetts license 223873.

Dr. Lakdawala's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Lakdawala's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Lakdawala is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Lakdawala to 3 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lakdawala practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Lakdawala's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Lakdawala is licensed in Massachusetts.

CMS data shows 1,540 Medicare services from Dr. Lakdawala across 11 procedure codes in 2024, for 964 Medicare patients. Medicare paid $39,755 for them.

CMS counts 964 Medicare patients who saw Dr. Lakdawala in 2024. The largest group is 75 to 84, with 367 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lakdawala's median patient age at 69, with 44% women.

In 2024, Dr. Lakdawala wrote 1,254 Medicare Part D claims for 173 patients. 69% of them were for generic drugs. CMS names the drug for 1,062 of them, across 26 drugs with 11 or more claims each, at $769,944 in total drug cost. In 2023, CMS named 1,125 claims across 29 drugs.

Dr. Lakdawala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lakdawala as offering telehealth.

Dmand AI links 124 papers to Dr. Lakdawala, published from 2010 to 2025. 2024 was the busiest year, with 16. The most frequent topics are Cardiomyopathy, Hypertrophic, Heart Failure and Cardiomyopathy, Dilated. Dr. Lakdawala has published most often in Circulation. Dr. Lakdawala's most frequent co-authors are Carolyn Yung Ho, MD, Anjali T. Owens, MD and Sara Saberi, MD.

Dmand AI links Dr. Lakdawala to 5 clinical trials, 2 of them phase 2 studies. Conditions studied include Heart Failure, Heart Diseases and Aortic Stenosis, Subvalvular. MyoKardia, Inc. sponsors the most, 2.

CMS Open Payments shows 18 general payments to Dr. Lakdawala from 5 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 99% of the total. Alexion Pharmaceuticals, Inc. paid the most, $16,730. It also lists 1 research payment totaling $1,400 in 2022.

Dr. Lakdawala graduated from University of Texas Medical School at San Antonio in 2001.